Breakdown | ||||
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
229.92M | 370.24M | 317.86M | 224.12M | 150.13M | Gross Profit |
211.35M | 289.69M | 244.50M | 166.42M | 102.90M | EBIT |
6.85M | 22.71M | 20.29M | 9.72M | 3.74M | EBITDA |
39.05M | 57.73M | 30.91M | 30.20M | 23.37M | Net Income Common Stockholders |
113.34M | -811.00K | -23.22M | -7.84M | -979.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
86.54M | 3.11M | 3.49M | 3.64M | 15.57M | Total Assets |
730.67M | 881.49M | 770.31M | 651.80M | 403.53M | Total Debt |
36.05M | 400.02M | 305.58M | 215.77M | 90.76M | Net Debt |
-50.50M | 396.91M | 302.09M | 212.13M | 75.19M | Total Liabilities |
215.32M | 553.20M | 462.62M | 362.21M | 163.36M | Stockholders Equity |
379.74M | 236.75M | 218.38M | 204.76M | 155.58M |
Cash Flow | Free Cash Flow | |||
48.41M | 18.13M | 33.40M | 38.57M | 17.77M | Operating Cash Flow |
48.41M | 34.50M | 45.85M | 46.77M | 23.72M | Investing Cash Flow |
396.15M | -121.52M | -113.05M | -156.31M | -35.43M | Financing Cash Flow |
-367.36M | 75.65M | 73.03M | 102.10M | 29.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $879.90M | 5.56 | 1.23% | ― | -27.40% | 21780.54% | |
73 Outperform | $1.26B | 24.89 | 24.36% | 1.42% | 4.90% | 9.91% | |
67 Neutral | $971.55M | 165.53 | 3.78% | ― | 9.54% | ― | |
67 Neutral | $1.08B | 17.76 | 6.35% | ― | -0.13% | 263.78% | |
65 Neutral | $930.10M | ― | -57.86% | ― | 16.35% | 14.27% | |
60 Neutral | $10.83B | 10.47 | -6.71% | 2.99% | 7.73% | -12.97% | |
59 Neutral | $1.11B | 157.07 | 0.89% | ― | 2.06% | -91.82% |
i3 Verticals reported an 8.8% increase in second-quarter revenue for 2025, reaching $63.1 million, and a net income of $1.1 million, reversing a loss from the previous year. The company completed the acquisition of a utility billing software company and divested its Healthcare Revenue Cycle Management business, aiming to focus on expanding its enterprise software offerings in the public sector.
Spark’s Take on IIIV Stock
According to Spark, TipRanks’ AI Analyst, IIIV is a Outperform.
I3 Verticals’ overall stock score reflects strong financial performance, particularly in profitability and cost management, coupled with a robust earnings call that highlights revenue and EBITDA growth. The technical indicators point to moderate upward momentum, though potential overbought conditions warrant caution. The low P/E ratio suggests the stock might be undervalued, offering a compelling investment opportunity. Overall, while revenue growth challenges and overbought technical conditions present risks, the company’s strategic focus and financial health position it well for future growth.
To see Spark’s full report on IIIV stock, click here.
On May 5, 2025, i3 Verticals, LLC, a subsidiary of i3 Verticals, Inc., completed the sale of its healthcare revenue cycle management business to Infinx, Inc. for $96 million in cash. This divestiture allows i3 Verticals to focus on its core operations in the Public Sector, particularly in the K-12 education market, while Infinx enhances its AI-driven solutions with the acquired expertise and technology.
Spark’s Take on IIIV Stock
According to Spark, TipRanks’ AI Analyst, IIIV is a Outperform.
I3 Verticals’ overall stock score reflects strong financial performance, particularly in profitability and cost management, coupled with a robust earnings call that highlights revenue and EBITDA growth. The technical indicators point to moderate upward momentum, though potential overbought conditions warrant caution. The low P/E ratio suggests the stock might be undervalued, offering a compelling investment opportunity. Overall, while revenue growth challenges and overbought technical conditions present risks, the company’s strategic focus and financial health position it well for future growth.
To see Spark’s full report on IIIV stock, click here.